nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—liver cancer—rectum cancer	0.368	0.395	CtDrD
Epirubicin—urinary bladder cancer—rectum cancer	0.295	0.317	CtDrD
Epirubicin—stomach cancer—rectum cancer	0.268	0.288	CtDrD
Epirubicin—CHD1—seminal vesicle—rectum cancer	0.00344	0.0548	CbGeAlD
Epirubicin—CHD1—urethra—rectum cancer	0.00272	0.0434	CbGeAlD
Epirubicin—CHD1—mammalian vulva—rectum cancer	0.00259	0.0413	CbGeAlD
Epirubicin—DHCR7—seminal vesicle—rectum cancer	0.00232	0.0369	CbGeAlD
Epirubicin—AURKA—renal system—rectum cancer	0.00223	0.0356	CbGeAlD
Epirubicin—CHD1—female reproductive system—rectum cancer	0.00222	0.0354	CbGeAlD
Epirubicin—YWHAG—seminal vesicle—rectum cancer	0.00213	0.0339	CbGeAlD
Epirubicin—AURKA—mammalian vulva—rectum cancer	0.00209	0.0333	CbGeAlD
Epirubicin—CHD1—vagina—rectum cancer	0.00201	0.032	CbGeAlD
Epirubicin—DHCR7—urethra—rectum cancer	0.00184	0.0292	CbGeAlD
Epirubicin—AURKA—female reproductive system—rectum cancer	0.00179	0.0285	CbGeAlD
Epirubicin—YWHAG—smooth muscle tissue—rectum cancer	0.00178	0.0284	CbGeAlD
Epirubicin—DHCR7—mammalian vulva—rectum cancer	0.00175	0.0278	CbGeAlD
Epirubicin—YWHAG—renal system—rectum cancer	0.00171	0.0273	CbGeAlD
Epirubicin—YWHAG—urethra—rectum cancer	0.00168	0.0268	CbGeAlD
Epirubicin—AURKA—vagina—rectum cancer	0.00162	0.0258	CbGeAlD
Epirubicin—YWHAG—mammalian vulva—rectum cancer	0.0016	0.0255	CbGeAlD
Epirubicin—PLA2G4A—seminal vesicle—rectum cancer	0.00159	0.0253	CbGeAlD
Epirubicin—UGT2B7—renal system—rectum cancer	0.00155	0.0247	CbGeAlD
Epirubicin—DHCR7—female reproductive system—rectum cancer	0.0015	0.0238	CbGeAlD
Epirubicin—AURKA—PLK1 signaling events—RAB1A—rectum cancer	0.0014	0.25	CbGpPWpGaD
Epirubicin—YWHAG—female reproductive system—rectum cancer	0.00137	0.0219	CbGeAlD
Epirubicin—DHCR7—vagina—rectum cancer	0.00135	0.0216	CbGeAlD
Epirubicin—PLA2G4A—smooth muscle tissue—rectum cancer	0.00133	0.0212	CbGeAlD
Epirubicin—CHD1—lymph node—rectum cancer	0.0013	0.0207	CbGeAlD
Epirubicin—PLA2G4A—renal system—rectum cancer	0.00128	0.0204	CbGeAlD
Epirubicin—PLA2G4A—urethra—rectum cancer	0.00126	0.02	CbGeAlD
Epirubicin—YWHAG—vagina—rectum cancer	0.00124	0.0198	CbGeAlD
Epirubicin—UGT2B7—female reproductive system—rectum cancer	0.00124	0.0198	CbGeAlD
Epirubicin—PLA2G4A—mammalian vulva—rectum cancer	0.0012	0.0191	CbGeAlD
Epirubicin—TOP2A—mammalian vulva—rectum cancer	0.00114	0.0181	CbGeAlD
Epirubicin—AURKA—lymph node—rectum cancer	0.00105	0.0167	CbGeAlD
Epirubicin—PLA2G4A—female reproductive system—rectum cancer	0.00102	0.0163	CbGeAlD
Epirubicin—PLA2G4A—vagina—rectum cancer	0.000926	0.0148	CbGeAlD
Epirubicin—ABCC1—seminal vesicle—rectum cancer	0.000908	0.0145	CbGeAlD
Epirubicin—TOP2A—vagina—rectum cancer	0.00088	0.014	CbGeAlD
Epirubicin—DHCR7—lymph node—rectum cancer	0.000875	0.0139	CbGeAlD
Epirubicin—YWHAG—lymph node—rectum cancer	0.000803	0.0128	CbGeAlD
Epirubicin—ABCC1—urethra—rectum cancer	0.000719	0.0114	CbGeAlD
Epirubicin—ABCC1—mammalian vulva—rectum cancer	0.000684	0.0109	CbGeAlD
Epirubicin—PLA2G4A—lymph node—rectum cancer	0.000599	0.00955	CbGeAlD
Epirubicin—TOP2A—lymph node—rectum cancer	0.000569	0.00907	CbGeAlD
Epirubicin—ABCC1—vagina—rectum cancer	0.00053	0.00844	CbGeAlD
Epirubicin—ABCC1—lymph node—rectum cancer	0.000343	0.00546	CbGeAlD
Epirubicin—AURKA—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.000217	0.0387	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—RAB1A—rectum cancer	0.000194	0.0346	CbGpPWpGaD
Epirubicin—AURKA—Aurora A signaling—TP53—rectum cancer	0.000165	0.0295	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.000164	0.0294	CbGpPWpGaD
Epirubicin—YWHAG—Activation of BH3-only proteins—TP53—rectum cancer	0.000149	0.0266	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—RAB1A—rectum cancer	0.000147	0.0262	CbGpPWpGaD
Epirubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—NRAS—rectum cancer	0.000145	0.0259	CbGpPWpGaD
Epirubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—KRAS—rectum cancer	0.000125	0.0223	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.000116	0.0206	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.000115	0.0205	CbGpPWpGaD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—rectum cancer	0.000106	0.019	CbGpPWpGaD
Epirubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—rectum cancer	0.000106	0.019	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—RAB1A—rectum cancer	0.000103	0.0184	CbGpPWpGaD
Epirubicin—YWHAG—LKB1 signaling events—TP53—rectum cancer	9.63e-05	0.0172	CbGpPWpGaD
Epirubicin—YWHAG—mTOR signaling pathway—NRAS—rectum cancer	8.93e-05	0.016	CbGpPWpGaD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—HRAS—rectum cancer	8.88e-05	0.0159	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—TP53—rectum cancer	8.75e-05	0.0156	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—TYMS—rectum cancer	8.13e-05	0.0145	CbGpPWpGaD
Epirubicin—YWHAG—mTOR signaling pathway—KRAS—rectum cancer	7.69e-05	0.0137	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—rectum cancer	6.88e-05	0.0123	CbGpPWpGaD
Epirubicin—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—rectum cancer	6.73e-05	0.012	CbGpPWpGaD
Epirubicin—YWHAG—mTOR signaling pathway—HRAS—rectum cancer	6.54e-05	0.0117	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	6.18e-05	0.011	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—NRAS—rectum cancer	6.16e-05	0.011	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	6.16e-05	0.011	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGF Pathway—HRAS—rectum cancer	6.03e-05	0.0108	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—TYMS—rectum cancer	5.91e-05	0.0106	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—TYMS—rectum cancer	5.63e-05	0.0101	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—NRAS—rectum cancer	5.36e-05	0.00958	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	5.34e-05	0.00953	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—KRAS—rectum cancer	5.3e-05	0.00948	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—KRAS—rectum cancer	5.23e-05	0.00935	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TYMS—rectum cancer	5.03e-05	0.00899	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—KRAS—rectum cancer	4.95e-05	0.00884	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—rectum cancer	4.82e-05	0.00862	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—TP53—rectum cancer	4.65e-05	0.00831	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—KRAS—rectum cancer	4.61e-05	0.00824	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—HRAS—rectum cancer	4.51e-05	0.00806	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—TYMS—rectum cancer	4.26e-05	0.00762	CbGpPWpGaD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—rectum cancer	4.22e-05	0.00754	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—HRAS—rectum cancer	4.21e-05	0.00751	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—HRAS—rectum cancer	4.11e-05	0.00734	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—HRAS—rectum cancer	3.92e-05	0.00701	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	3.83e-05	0.00685	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TYMS—rectum cancer	3.81e-05	0.00681	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ITGA2—rectum cancer	3.78e-05	0.00675	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—TP53—rectum cancer	3.45e-05	0.00617	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—NRAS—rectum cancer	3.25e-05	0.0058	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—TYMS—rectum cancer	2.98e-05	0.00533	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—TYMS—rectum cancer	2.93e-05	0.00524	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—KRAS—rectum cancer	2.8e-05	0.00499	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TYMS—rectum cancer	2.67e-05	0.00476	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—HRAS—rectum cancer	2.38e-05	0.00425	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	2.3e-05	0.00411	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	2.04e-05	0.00365	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	1.99e-05	0.00356	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—rectum cancer	1.96e-05	0.0035	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	1.77e-05	0.00316	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TP53—rectum cancer	1.67e-05	0.00298	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—rectum cancer	1.26e-05	0.00226	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NRAS—rectum cancer	1.06e-05	0.0019	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—TYMS—rectum cancer	1.01e-05	0.00181	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—TYMS—rectum cancer	9.92e-06	0.00177	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—KRAS—rectum cancer	9.13e-06	0.00163	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—rectum cancer	8.84e-06	0.00158	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—rectum cancer	8.12e-06	0.00145	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—TYMS—rectum cancer	7.93e-06	0.00142	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—HRAS—rectum cancer	7.76e-06	0.00139	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—NRAS—rectum cancer	6.09e-06	0.00109	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—KRAS—rectum cancer	5.24e-06	0.000937	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—HRAS—rectum cancer	4.46e-06	0.000796	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NRAS—rectum cancer	4.1e-06	0.000733	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NRAS—rectum cancer	3.6e-06	0.000643	CbGpPWpGaD
Epirubicin—ABCC1—Disease—KRAS—rectum cancer	3.53e-06	0.000631	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KRAS—rectum cancer	3.1e-06	0.000553	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HRAS—rectum cancer	3e-06	0.000537	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—rectum cancer	2.75e-06	0.000492	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HRAS—rectum cancer	2.63e-06	0.00047	CbGpPWpGaD
